Cawachi Limited (2664) AI Stock Analysis

• Market Cap: ¥67.63B
• Dividend Yield: 2.68%
• Average Volume (3M): 35.49K
• Price to Earnings (P/E): 16.6
• Beta (1Y): 0.37
• Revenue Growth: -0.56%
• EPS Growth: 5.59%
• Country: JP
• Employees: 2,722
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Pharmaceuticals
• EPS (TTM): 45.10
• Shares Outstanding: 24,583,420
• 10 Day Avg. Volume: 30,120
• 30 Day Avg. Volume: 35,490
• PEG Ratio: 3.54
• Price to Book (P/B): 0.55
• Price to Sales (P/S): 0.22
• P/FCF Ratio: 18.47
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 72 Outperform
• Price Target: ¥3,363.00 ▲(11.17% Upside)
• Action: Reiterated Date: 08/21/25
• Date: Action: Reiterated 08/21/25

Cawachi Limited's strong financial position and reasonable valuation are the primary strengths, contributing to a solid overall score. The technical analysis indicates stability but lacks strong momentum, while the absence of earnings call and corporate events data limits additional insights.

Positive Factors

Balance Sheet Strength

Very low leverage and a high equity ratio give the company durable financial flexibility. With a debt-to-equity of 0.15 and strong equity base, Cawachi can fund store investment, absorb shocks, and pursue opportunistic capex or M&A without stressing liquidity, supporting multi-month resilience.

Negative Factors

Low Net Profitability

A sub-2% net margin leaves little buffer for adverse cost or sales shocks and limits reinvestment capacity. Over the medium term this constrains the company's ability to expand margins, increase returns to shareholders, or absorb rising operating costs in the retail pharmacy environment.

Cawachi Limited Business Overview & Revenue Model

Company Description

Cawachi Limited manages drugstores in Japan. The company retails pharmaceuticals, health foods, childcare products, cosmetics, daily miscellaneous goods, general food products, confectionery products, etc. It also involved in the insurance busines...

Read more

Cawachi Limited manages drugstores in Japan. The company retails pharmaceuticals, health foods, childcare products, cosmetics, daily miscellaneous goods, general food products, confectionery products, etc. It also involved in the insurance busines...

How the Company Makes Money

Cawachi Limited primarily makes money through retail sales at its drugstore locations. Its main revenue stream comes from selling (1) prescription-related and over-the-counter pharmaceutical products, (2) health and beauty products (e.g., personal...

Read more

Cawachi Limited primarily makes money through retail sales at its drugstore locations. Its main revenue stream comes from selling (1) prescription-related and over-the-counter pharmaceutical products, (2) health and beauty products (e.g., personal...

Cawachi Limited Financial Statement Overview

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	287.50B	287.82B	285.96B	281.87B	279.46B	284.49B
Gross Profit	66.44B	66.66B	65.80B	64.05B	63.15B	64.68B
EBITDA	10.85B	11.36B	11.49B	10.90B	12.16B	15.17B
Net Income	4.75B	4.88B	4.71B	4.18B	4.83B	7.11B
Balance Sheet
Total Assets	203.63B	200.96B	197.24B	195.24B	192.48B	194.86B
Cash, Cash Equivalents and Short-Term Investments	40.72B	36.67B	35.62B	38.45B	38.96B	41.23B
Total Debt	17.92B	16.60B	16.73B	19.55B	22.92B	26.41B
Total Liabilities	89.95B	86.55B	85.94B	87.51B	87.83B	94.00B
Stockholders Equity	113.68B	114.41B	111.30B	107.72B	104.65B	100.86B
Cash Flow
Free Cash Flow	0.00	3.40B	1.02B	4.11B	2.37B	12.09B
Operating Cash Flow	0.00	7.48B	6.40B	9.82B	6.87B	15.27B
Investing Cash Flow	0.00	-4.51B	-5.29B	-5.84B	-4.54B	-3.15B
Financing Cash Flow	0.00	-1.92B	-3.94B	-4.49B	-4.61B	-3.98B

Cawachi Limited Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 3025.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2664, the sentiment is Positive. The current price of 3025 is above the 20-day moving average (MA) of 2998.80, above the 50-day MA of 3021.15, and above the 200-day MA of 2861.26, indicating a bullish trend. The MACD of 13.36 indicates Negative momentum. The RSI at 51.78 is Neutral, neither overbought nor oversold. The STOCH value of 65.85 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:2664.

Cawachi Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
2664	72 Outperform	¥67.63B	16.62	―	2.68%	-0.56%	5.59%
9989	69 Neutral	¥453.20B	14.05	11.37%	3.04%	6.32%	8.19%
3549	67 Neutral	¥357.89B	16.82	―	0.41%	15.81%	27.05%
7649	66 Neutral	¥665.13B	14.44	15.71%	0.96%	21.81%	67.76%
3391	62 Neutral	¥979.56B	19.41	―	1.72%	―	―
3349	60 Neutral	¥511.03B	22.79	―	0.93%	3.73%	18.84%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

Cawachi Limited Corporate Events